Conmed (FRA:EC8) E10: €1.34 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EC8 Conmed Corp FRA:EC8
81 GF Score
Price €43.80
GF Value €57.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Conmed E10?

Conmed FRA:EC8 81 E10 is €1.34 as of Jun. 2026. GuruFocus rates FRA:EC8 with a GF Score™ of 81/100 and a GF Value™ of €57.51 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Conmed's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.668. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.34 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Conmed's average E10 Growth Rate was 10.70% per year. During the past 3 years, the average E10 Growth Rate was 12.40% per year. During the past 5 years, the average E10 Growth Rate was 3.70% per year. During the past 10 years, the average E10 Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Conmed was 26.80% per year. The lowest was -5.70% per year. And the median was 4.50% per year.

As of today (2026-08-21), Conmed's current stock price is €43.80. Conmed's E10 for the quarter that ended in Jun. 2026 was €1.34. Conmed's Shiller PE Ratio of today is 32.69.

During the past 13 years, the highest Shiller PE Ratio of Conmed was 142.78. The lowest was 21.83. And the median was 69.69.


Conmed  (FRA:EC8) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Conmed's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=43.80/1.34
=32.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Conmed was 142.78. The lowest was 21.83. And the median was 69.69.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Conmed E10 Related Terms


Conmed E10 Historical Data

* Premium members only.

The historical data trend for Conmed's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed E10 Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 0.91 0.97 1.32 1.20

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 1.13 1.20 1.27 1.34

FRA:EC8 vs ATEC, AORT, IRMD: E10 Comparison

For the Medical Devices subindustry, Conmed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Conmed's Shiller PE Ratio falls into.


FRA:EC8
81GF Score
Conmed Corp FRA:EC8
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.668/333.9520*333.9520
=0.668

Current CPI (Jun. 2026) = 333.9520.

Conmed Quarterly Data

per share eps CPI Adj_EPS
201609 0.232 241.428 0.321
201612 0.228 241.432 0.315
201703 -0.150 243.801 -0.205
201706 0.196 244.955 0.267
201709 0.218 246.819 0.295
201712 1.394 246.524 1.888
201803 0.300 249.554 0.401
201806 0.257 251.989 0.341
201809 0.171 252.439 0.226
201812 0.475 251.233 0.631
201903 0.035 254.202 0.046
201906 0.168 256.143 0.219
201909 0.209 256.759 0.272
201912 0.441 256.974 0.573
202003 0.181 258.115 0.234
202006 -0.852 257.797 -1.104
202009 0.195 260.280 0.250
202012 0.666 260.474 0.854
202103 0.260 264.877 0.328
202106 0.340 271.696 0.418
202109 0.400 274.310 0.487
202112 0.664 278.802 0.795
202203 0.427 287.504 0.496
202206 -5.345 296.311 -6.024
202209 1.495 296.808 1.682
202212 0.812 296.797 0.914
202303 0.056 301.836 0.062
202306 0.397 305.109 0.435
202309 0.469 307.789 0.509
202312 0.963 306.746 1.048
202403 0.580 312.332 0.620
202406 0.892 314.175 0.948
202409 1.415 315.301 1.499
202412 1.031 315.605 1.091
202503 0.176 319.799 0.184
202506 0.598 322.561 0.619
202509 0.077 324.800 0.079
202512 0.461 324.054 0.475
202603 0.389 330.213 0.393
202606 0.668 333.952 0.668

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.34 mean?
Conmed (FRA:EC8) has a E10 of €1.34 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Conmed and its competitors.
Is Conmed's E10 too high?
Conmed's current E10 is €1.34. Overall, Conmed has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Conmed's E10 compare to ATEC and AORT?
Conmed's E10 of €1.34 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Conmed and its competitors. Conmed's current E10 is €1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Based on GuruFocus' analysis, Conmed (FRA:EC8) is currently considered Modestly Undervalued. The stock's GF Value™ is €57.51, compared to a current price of €43.80 — trading 23.8% below its estimated fair value. The current E10 is €1.34. Conmed's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Conmed (FRA:EC8), the current E10 is €1.34 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (FRA:EC8) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of €43.80 is trading 23.8% below its estimated GF Value™ of €57.51. GuruFocus considers Conmed to be Modestly Undervalued.

Key valuation signals for FRA:EC8:

  • E10: €1.34
  • GF Value™: €57.51 vs. price of €43.80 (23.8% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:EC8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
81GF Score

Get the complete analysis for FRA:EC8

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.80
Price
€57.51
GF Value